Image

Disparities in Myocardial Infarction Remodeling According to Gender

Disparities in Myocardial Infarction Remodeling According to Gender

Recruiting
18 years and older
All
Phase N/A
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

Following myocardial infarction, female individuals demonstrate a poorer prognosis, characterized by elevated rates of mortality and heart failure. A primary hypothesis suggests unfavorable cardiac remodeling in women. This remodeling, defined as alterations in cardiac size and shape post-infarction, necessitates repeated non-invasive imaging for study.

Eligibility

Inclusion Criteria:

  • Age > 18 years
  • First myocardial infarction with ST-segment elevation during the hospital phase
  • Coronary angiography performed within 72 hours of the infarction
  • Inclusion in the RIMA registry
  • Patient affiliated or beneficiary of a social security scheme; Signature of informed consent

Exclusion Criteria:

  • Patients already enrolled in the study
  • Poor understanding of the French language
  • Pregnant, breastfeeding, or postpartum women
  • Individuals deprived of liberty by judicial or administrative decision; Individuals receiving psychiatric care under coercion
  • Individuals subject to a legal protection measure; Individuals incapable of giving consent

Study details
    Myocardial Infarction
    Ventricular Remodeling

NCT06343844

University Hospital, Angers

15 October 2025

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.